Laparoscopic versus conventional Nissen fundoplication: the influence on plasma insulin-like growth factor-I and insulin-like growth factor binding protein-3. 1999

C Sietses, and M J Wiezer, and P A van Leeuwen, and R H Beelen, and M A Cuesta
Department of Surgery, Academic Hospital Vrije Universiteit, De Boelelaan 1117, 1081 HV, Amsterdam, The Netherlands.

BACKGROUND Conventional surgery is known to influence postoperative insulin-like growth factor-I (IGF-I) levels and to increase protein breakdown. Recent animal data described that laparoscopic surgery, in contrast to conventional surgery, maintains postoperative IGF-I levels, suggesting a reduced postoperative catabolic response. OBJECTIVE The aim of this study was to demonstrate differences in the postoperative catabolic response between laparoscopic and conventional surgery. METHODS Seventeen patients scheduled for Nissen fundoplication were randomly assigned to undergo either a laparoscopic or a conventional procedure. The catabolic response was assessed by measuring total IGF-I and insulin-like growth factor binding protein-3 (IGFBP-3). RESULTS IGF-I levels decreased significantly 4 days after both types of surgery. IGFBP-3 decreased more rapidly after conventional surgery than after the laparoscopic technique; however, the differences between the groups were not significant. CONCLUSIONS In contrast to animal data, no differences in plasma IGF-I or IGFBP-3 were seen in patients undergoing laparoscopic or conventional Nissen fundoplication.

UI MeSH Term Description Entries
D007334 Insulin-Like Growth Factor I A well-characterized basic peptide believed to be secreted by the liver and to circulate in the blood. It has growth-regulating, insulin-like, and mitogenic activities. This growth factor has a major, but not absolute, dependence on GROWTH HORMONE. It is believed to be mainly active in adults in contrast to INSULIN-LIKE GROWTH FACTOR II, which is a major fetal growth factor. IGF-I,Somatomedin C,IGF-1,IGF-I-SmC,Insulin Like Growth Factor I,Insulin-Like Somatomedin Peptide I,Insulin Like Somatomedin Peptide I
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010535 Laparoscopy A procedure in which a laparoscope (LAPAROSCOPES) is inserted through a small incision near the navel to examine the abdominal and pelvic organs in the PERITONEAL CAVITY. If appropriate, biopsy or surgery can be performed during laparoscopy. Celioscopy,Laparoscopic Surgical Procedures,Peritoneoscopy,Surgical Procedures, Laparoscopic,Laparoscopic Assisted Surgery,Laparoscopic Surgery,Laparoscopic Surgical Procedure,Procedure, Laparoscopic Surgical,Procedures, Laparoscopic Surgical,Surgery, Laparoscopic,Surgical Procedure, Laparoscopic,Celioscopies,Laparoscopic Assisted Surgeries,Laparoscopic Surgeries,Laparoscopies,Peritoneoscopies,Surgeries, Laparoscopic,Surgeries, Laparoscopic Assisted,Surgery, Laparoscopic Assisted
D011184 Postoperative Period The period following a surgical operation. Period, Postoperative,Periods, Postoperative,Postoperative Periods
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D018662 Fundoplication Mobilization of the lower end of the esophagus and plication of the fundus of the stomach around it (fundic wrapping) in the treatment of GASTROESOPHAGEAL REFLUX that may be associated with various disorders, such as hiatal hernia. (From Dorland, 28th ed) Nissen Operation,Operation, Nissen
D018972 Insulin-Like Growth Factor Binding Protein 3 One of the six homologous soluble proteins that bind insulin-like growth factors (SOMATOMEDINS) and modulate their mitogenic and metabolic actions at the cellular level. IGF-Binding Protein 3,IGFBP-3,IGF Binding Protein 3,Protein 3, IGF-Binding

Related Publications

C Sietses, and M J Wiezer, and P A van Leeuwen, and R H Beelen, and M A Cuesta
September 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology,
C Sietses, and M J Wiezer, and P A van Leeuwen, and R H Beelen, and M A Cuesta
September 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology,
C Sietses, and M J Wiezer, and P A van Leeuwen, and R H Beelen, and M A Cuesta
January 2014, JSLS : Journal of the Society of Laparoendoscopic Surgeons,
C Sietses, and M J Wiezer, and P A van Leeuwen, and R H Beelen, and M A Cuesta
September 1992, Cancer research,
C Sietses, and M J Wiezer, and P A van Leeuwen, and R H Beelen, and M A Cuesta
June 2000, Journal of the American Academy of Dermatology,
C Sietses, and M J Wiezer, and P A van Leeuwen, and R H Beelen, and M A Cuesta
December 2012, The Journal of clinical endocrinology and metabolism,
C Sietses, and M J Wiezer, and P A van Leeuwen, and R H Beelen, and M A Cuesta
January 2005, Biological trace element research,
C Sietses, and M J Wiezer, and P A van Leeuwen, and R H Beelen, and M A Cuesta
September 2005, Urology,
C Sietses, and M J Wiezer, and P A van Leeuwen, and R H Beelen, and M A Cuesta
July 2000, Cancer research,
C Sietses, and M J Wiezer, and P A van Leeuwen, and R H Beelen, and M A Cuesta
January 2005, Drugs in R&D,
Copied contents to your clipboard!